Coeptis Therapeutics Holdings Inc. Common Stock
COEPCoeptis Therapeutics Holdings Inc. (COEP) is a biotechnology company focused on developing innovative therapies for conditions with unmet medical needs. The company's mission centers on leveraging its proprietary delivery platforms and scientific expertise to advance treatments in areas such as oncology and infectious diseases. Coeptis aims to improve patient outcomes through novel medications and strategic collaborations within the pharmaceutical industry.
Company News
Coeptis Therapeutics (NASDAQ: COEP) announced that its S-4 registration statement has been declared effective by the SEC, and proxy materials are being mailed to stockholders for a vote on the merger with Z Squared Inc., scheduled for January 30, 2026. The combined company has applied for Nasdaq listing but approval is not yet assured.
Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies, including Sage Therapeutics, Coeptis Therapeutics, and AvidXchange Holdings.
Law firm Monteverde & Associates is investigating potential merger issues for four companies: Coeptis Therapeutics, Regional Health Properties, Pacific Premier Bancorp, and Southport Acquisition Corporation.
Coeptis Therapeutics has filed a registration statement with the SEC regarding a proposed merger with Z Squared Inc., a digital asset compute mining company. The Form S-4 includes a preliminary proxy statement/prospectus about the transaction.
COEPTIS and MarketLeverage have partnered to integrate AI technology with performance-based affiliate marketing strategies, aiming to provide advanced automation, data-driven insights, and seamless campaign optimization for affiliates, brands, and marketers.
